Roy L, Chomel JC, Guilhot J, Guerci-Bresler A, et al. Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study). Br J Haematol 2023;200:175-186.
PMID: 36214090